Searched for
INNOVENT BIOLOGICS PARTNERSHIP
Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...- Telangana plans drug discovery push to move Hyderabad up pharma value chainTelangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- The spy who hired me: Chinese agents hunt for secrets on LinkedInChinese intelligence is now using professional networking sites and job portals to find and recruit people with access to sensitive data. T...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Biotech startup StrainX Bioworks raises $13 million from Prime Venture, Leo Capital, othersStrainX Bioworks, a synthetic biology and precision fermentation startup, has raised $13 million to advance its biotechnology platform. The...
- India, Chile expedite CEPA negotiations and critical minerals cooperationChile's Foreign Minister Francisco Pérez Mackenna's visit to India boosted bilateral ties, focusing on CEPA negotiations, critical minerals...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Karnataka launches India’s first state-led spacetech CoE in BengaluruKarnataka has launched India's first state-led Centre of Excellence for Space Technology (CoE SpaceTech Foundation) in Bengaluru. This init...
- Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...
- India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...
- Biologicals "at forefront" of agricultural shift, says Syngenta India chiefSyngenta India's head Susheel Kumar highlighted the transformative potential of biologicals in ensuring food security at the BioAg World Co...
- Mankind Pharma inks licensing pact with Innovent to commercialise Sintilimab in IndiaMankind Pharma Ltd and Innovent Biologics have partnered to license and commercialise the cancer immunotherapy drug Sintilimab in India. Th...
- IIL ties up with BioPrime to introduce biological product 'Relieve' in IndiaInsecticides India and BioPrime joined forces. They launched Relieve in India. Relieve is a seaweed and plant-based product. It boosts crop...
- Sanchiconnect partners with BITS Pilani, AIC-CCMB to help deep-tech platforms tie up with enterprisesThe partnership will provide free hand access to over 90 global institutional investors in deep-tech along with business challenges from pr...
- Mylab partners with Shilpa Biologicals to enter vaccines & therapeutics segmentAdar Poonawalla-backed Mylab plans to develop world-class diagnostics, vaccines and therapeutics to augment its presence in the healthcare ...
- CEPI to invest $5m in Biological E’s projectCEPI has also agreed to an initial contribution of up to $5 million to Hyderabad-based Biological E towards the cost of scaling up the proc...
- Buy Biocon, target Rs 880: Phillip Capital (India)Buy Biocon at a price target of Rs 880.
Load More
